Krystal Biotech, Inc. (KRYS)

CIK 0001711279 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-03) · 99.1
Q1-2026 —
Latest FY-2025 8-K (2026-02-17) · 99.1  |  8-K (2026-01-12) · 99.1
Q3-2025 8-K (2025-11-03) · 99.1
Q2-2025 8-K (2025-08-04) · 99.1
Q1-2025 8-K (2025-05-06) · 99.1
FY-2024 —
Q3-2024 8-K (2024-11-04) · 99.1
Q2-2024 8-K (2024-08-05) · 99.1
Q1-2024 8-K (2024-05-06) · 99.1
FY-2023 8-K (2024-02-26) · 99.1
Q3-2023 8-K (2023-11-06) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)
—
Consolidated Statements of Operations and Comprehensive Income
Consolidated Statements of Operations and Comprehensive Income (loss)
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Consolidated Statements of Stockholders' Equity (P)
Notes
Balance Sheet Components
Capitalization
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Fair Value Instruments
Gain From Sale of Priority Review Voucher
—
Gain On Sale of Priority Review Voucher
—
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Leases
Net Income (loss) Per Share Attributable To Common Stockholders
Net Income Per Share Attributable To Common Stockholders
Organization
Pay Vs Performance Disclosure
Product Revenue, Accounts Receivable and Reserves For Product Sales
Revenue Recognition
Segment Information
Stock-based Compensation
Subsequent Events
Summary of Significant Accounting Policies